Taldeki Biosolutions: A New Generation of Biosensors for Advanced Diagnostics
Vertical: Personalised health
Project description
Taldeki Biosolutions is pioneering a new generation of metal-protein hybrid sensors for antibody and biomarker detection, offering an innovative and more efficient alternative to traditional antibodies and nanobodies. Its technology enables the rapid development of diagnostic tests with greater stability, higher reproducibility, and lower production costs.
Taldeki’s innovation is based on the MELISA platform, developed and patented by CIC biomaGUNE and licensed to Taldeki Biosolutions, which provides:
- Elimination of antibodies, reducing costs and increasing diagnostic stability.
- Flexible design, allowing the detection of multiple biomarkers in a single test.
- Ultra-sensitive detection using metal-protein hybrid nanosensors.
- Greater stability and reproducibility compared to traditional antibody-based methods.
Market
Taldeki’s technology has high-impact potential in the diagnostics sector and for detecting multiple biomolecules, with applications in:
- Type 1 Diabetes – Early detection of key autoantibodies (GAD65, IA-2A, IAA, ZnT8A).
- Infectious Disease Diagnosis – Rapid, cost-effective serological detection.
- Personalised Medicine – Development of biosensors tailored to specific clinical needs.
- R&D Reagents – Capable of detecting multiple analytes for research applications.
Technology tags
Business model
Project needs
Promoted by
Are you interested in high-tech projects capable of generating greater market impact?
Fill in this form and we will contact you if you want to take part in this initiative – either by contributing technology assets or if you are a talent promoter capable of turning them into business projects.
Related news
SAFEMOB: artificial intelligence for safer and more efficient public transport
Basque Tek Ventures backs this project that integrates AI in passenger vehicles to anticipate incidents and improve the travel experience
RECONNECT: spinal cord reconnection for people with spinal cord injuries
Basque Tek Ventures promotes this disruptive project that seeks to restore lost functions through state-of-the-art biocompatible implants
ILARGIA: AI-based platform for de novo protein design and optimisation
The project, powered by Basque Tek Ventures, promotes advanced biotechnological solutions for laboratories, academia and companies through an end-to-end approach
BEGI: on-chip 3D vision processor with back-end AI systems to enable neuromorphic DVS sensors
Basque Tek Ventures promotes this initiative to offer a new generation of three-dimensional perception in real time, more efficient and sustainable
Prospect Biotech: real-time analysis of cell cultures using light
Basque Tek Ventures is backing this project that offers an optic solution to develop and monitor advanced therapies.
Makby: 3D bioprinting software for regenerative medicine
Basque Tek Ventures is backing this initiative that will revolutionise the field of artificial biological tissues.
Konbus+: Controlled temperature and high velocity thermal spray systems
The initiative, coming under Basque Tek Ventures, provides high value-added coatings in extreme conditions in a cost-effective manner.
K-ALMA: Generative AI for reliable software tests
Basque Tek Ventures is backing this project that automates the code validations by reducing their high certification cost.
INTELLIWELD: assessment of weld quality
Basque Tek Ventures supports this initiative offering an integrated system to analyse and control process and product in welding systems.
FATRIXGEL: universal biomaterial for 3D cell cultures
The project, coming under Basque Tek Ventures, will revolutionise the generation of tissues to be used to research pharmaceutical and biotechnological therapies.